OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 136 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $3,000 | -40.0% | 7,200 | -13.3% | 0.00% | – |
| Q1 2016 | $5,000 | -75.0% | 8,300 | -30.2% | 0.00% | – |
| Q4 2015 | $20,000 | -58.3% | 11,885 | -48.2% | 0.00% | – |
| Q3 2015 | $48,000 | -55.1% | 22,942 | +6.6% | 0.00% | – |
| Q2 2015 | $107,000 | -11.6% | 21,520 | +38.8% | 0.00% | – |
| Q1 2015 | $121,000 | -88.6% | 15,500 | -91.1% | 0.00% | -100.0% |
| Q4 2014 | $1,059,000 | +45.9% | 174,772 | +2.5% | 0.00% | – |
| Q3 2014 | $726,000 | -24.1% | 170,543 | +10.1% | 0.00% | -100.0% |
| Q2 2014 | $957,000 | +6.3% | 154,878 | +11.9% | 0.00% | 0.0% |
| Q1 2014 | $900,000 | +28.0% | 138,416 | +10.9% | 0.00% | – |
| Q4 2013 | $703,000 | -18.4% | 124,816 | -11.2% | 0.00% | -100.0% |
| Q3 2013 | $862,000 | +788.7% | 140,575 | +752.0% | 0.00% | – |
| Q2 2013 | $97,000 | – | 16,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 3,000,000 | $5,160,000 | 4.58% |
| Foresite Capital Management II, LLC | 6,225,049 | $10,707,000 | 3.59% |
| Scale Management, LLC | 1,312,575 | $2,258,000 | 3.46% |
| NEA Management Company, LLC | 3,709,000 | $6,379,000 | 0.41% |
| Cheyne Capital Management (UK) LLP | 413,200 | $709,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,189,000 | $2,045,000 | 0.31% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $10,596,000 | 0.22% |
| Rock Springs Capital Management LP | 1,650,000 | $2,838,000 | 0.22% |
| Palo Alto Investors LP | 1,673,024 | $2,878,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 295,000 | $507,000 | 0.14% |